[HTML][HTML] Diversity of HIV-1 genotypes and high prevalence of pretreatment drug resistance in newly diagnosed HIV-infected patients in Shanghai, China

Z Wang, M Zhang, R Zhang, L Liu, Y Shen… - BMC infectious …, 2019 - Springer
… was amplified using a nested polymerase chain reaction. … of PDR highlights the significance
of baseline HIV-1 drug … based on Stanford University HIV Drug Resistance Database (HIVDB…

Pre‐treatment and acquired antiretroviral drug resistance among people living with HIV in Tianjin, China

L Gao, H Xia, R Zeng, Y Wu, SD Zaongo, Y Hu… - HIV …, 2022 - Wiley Online Library
… people living with HIV (PLWH) on antiretroviral therapy (ART) … baseline genotypic resistance
testing and adequate intervals … public health response to pretreatment HIV drug resistance. …

Deep sequencing of HIV-1 reveals extensive subtype variation and drug resistance after failure of first-line antiretroviral regimens in Nigeria

K El Bouzidi, RP Datir, V Kwaghe, S Roy… - … of Antimicrobial …, 2022 - academic.oup.com
… , which found no association between baseline minority variants … -1 cleavage sites, may also
affect the response to therapy. … virological outcomes of first-line antiretroviral therapy for HIV-…

[HTML][HTML] Antiretroviral drug use by individuals living with HIV/AIDS and compliance with the Clinical Protocol and Therapy Guidelines

LEF Brojan, LM Marca, FA Dias, YD Rattmann - Einstein (Sao Paulo), 2020 - SciELO Brasil
… second and third lines of antiretroviral therapy, respectively. Some … , adverse reactions, drug
interactions, and resistance of HIV to … Baseline HIV-1 resistance, virological outcomes, and …

Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited …

ENJ Semengue, D Armenia, S Inzaule… - … of Antimicrobial …, 2021 - academic.oup.com
… in terms of viral pathogenesis and treatment response. This is … trends of efavirenz/nevirapine
pre-treatment drug resistance (… Curbing the rise of HIV drug resistance in low-income and …

Predictors of virological failure and time to viral suppression of first-line integrase inhibitor–based antiretroviral treatment

A Pyngottu, AU Scherrer, R Kouyos… - Clinical infectious …, 2021 - academic.oup.com
… In 646 patients with a baseline genotypic resistance test of … Failure of potent antiretroviral
therapy is associated with … the Swiss HIV Cohorts Study (SHCS) and the SHCS drug resistance

Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL

N Gianotti, P Lorenzini, A Cozzi-Lepri… - … of Antimicrobial …, 2019 - academic.oup.com
… with the anchor drug class if the baseline HIV-RNA was >… test between baseline HIV-RNA
and the anchor drug class … virological response, no virological response by week 32, HIV-…

Consequences of HIV/syphilis co-infection on HIV viral load and immune response to antiretroviral therapy

L Fan, A Yu, D Zhang, Z Wang, P Ma - … and drug resistance, 2021 - Taylor & Francis
… failure during HIV treatment was also … , HIV viral load at baseline was not included in the
medical records and we could not exclude the effect of baseline viral load on immune response. …

Clinical outcomes following the use of archived proviral HIV-1 DNA genotype to guide antiretroviral therapy adjustment

KE Ellis, GT Nawas, C Chan, L York… - Open forum …, 2020 - academic.oup.com
… by polymerase chain reaction (PCR), … to drug resistance (24%), DNA GT confirmed
susceptibility to current regimen (18%), and patient did not follow up (6%). Baseline characteristics of

Three-year study of pre-existing drug resistance substitutions and efficacy of bictegravir/emtricitabine/tenofovir alafenamide in HIV-1 treatment-naive participants

RK Acosta, GQ Chen, S Chang, R Martin… - … of Antimicrobial …, 2021 - academic.oup.com
resistance analysis and impact of baseline resistance substitutions on treatment response
… substitutions used in these analyses is based on the IAS-USA list of HIV drug resistance